ArticleFrontiers in psychiatry2026

Treatment non-persistence in children and adolescents with Tourette syndrome newly treated with dopamine D2 receptor modulators.

Kinga K Tomczak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.